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ABSTRACT
The use of substances to augment soft tissues as aesthetic purpose is associated with, among other undesirable effects, the 
appearance of foreign body granulomas. The improvements made to these substances have reduced the incidence of adverse 
reactions, but not eliminated them. We present five cases of foreign body reactions to three different products, dimethylpolysi-
loxane (silicone), bovine collagen, and polylactic acid, which were injected into the subcutaneous cellular tissue of the patients 
(all five were women), between two and sixteen years before the appearance of the foreign body reaction. All five presented 
painless, diffuse facial tumefaction, of firm, elastic consistency. The magnetic resonance image (MRI) studies showed signs 
of intense inflammatory reaction in the affected areas.
The histology revealed the presence of foreign body granulomas with giant multi-nucleated cells.
The patients were treated with systemically administered corticoids, except in one case which did not require pharmacological 
treatment.
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RESUMEN
El uso de sustancias para el aumento de tejidos blandos por motivos estéticos puede ocasionar la aparición de granulomas a 
cuerpo extraño, entre otros efectos indeseables. Las mejoras introducidas en dichas sustancias han conseguido la disminución 
de la incidencia de reacciones adversas pero no su desaparición. Presentamos cinco casos de reacción a cuerpo extraño por 
tres productos diferentes (dimetilpolisiloxano –silicona-, colágeno bovino, y ácido poliláctico) que habían sido infiltrados en el 
tejido celular subcutáneo de las pacientes (las cinco eran mujeres) entre dos y dieciséis años antes de la aparición de la reacción 
a cuerpo extraño. Las cinco presentaron un cuadro de tumefacción facial difusa, no dolorosa y de consistencia duroelástica. 
Los estudios de imagen  con resonancia magnética mostraron signos de reacción inflamatoria intensa de la zona afectada.
La histología mostró la presencia de granulomas a cuerpo extraño con células gigantes multinucleadas.
Las pacientes fueron tratadas con corticoides administrados por vía sistémica, excepto una de ellas que no precisó tratamiento 
farmacológico.
Palabras clave: Granuloma, siliconoma, ácido poliláctico, silicona, colágeno bovino.
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INTRODUCTION
The use of filler substances to augment soft tissues dates back 
to the end of the 19th century. Initially autologous fat was 
used, later paraffin, silicone, and bovine collagen, with a long, 
and ever increasing list of products to the present day (1). The 
mechanism is similar in all types: these are supposedly inert 
materials that on being introduced into the integument cause 
an increase in the volume ‘per se’ and a progressive infiltration 
of a collagen matrix which in turn contributes to the increase 
in volume (2).
Liquid silicone is derived from dimethylsiloxane polymers. It 
is administered following the microdrop injection technique 
described by Orentreich (3).
Bovine collagen is the substance most used at present, and cons-
titutes the standard reference for the remaining filler materials. 
Multiple presentations of the product have been tried (associa-
ted to polymetacrylate spheres, to solubilized elastin peptides, 
in monomolecular form at 2% in aqueous solution, etc.).
Polylactic acid is a non-animal product presented in a lyophili-
zed (freeze-dried) form and requires reconstitution with water 
before it is injected (1).
The use of these products is associated with certain undesirable 




Fifty-five year-old woman, smoker of two packets of cigarettes 
a day, and occasional consumer of alcohol. Insulin dependent 
diabetes and with a stomach ulcer. Under treatment with in-
sulin, citalopram, lorazepam, calcium dobesilate, raloxifene 
and atorvastatin.
She was referred to our service presenting a tumefaction on the 
lower part of both genian areas, the left lower lip and the right 
nasogenian sulcus of one month’s evolution, slow progressively 
growing, elastic in consistency, and painless (fig. 1). The patient 
noted that she felt worse in the mornings. She reported how 
she had received first local infiltrations of polylactic acid and 
then botulinum toxin typeA (Botox®) nine years, and one and 
a half years ago respectively. A blood analysis, orthopantomo-
graph, MRI and a biopsy were requested. The analysis and the 
orthopantomograph did not reveal any significant alterations. 
The MRI showed hyperintense images of the mandibular and 
submandibular subcutaneous fat with discrete trabeculation 
related to inflammatory changes. The biopsy informed of chro-
nic inflammatory infiltrate with eosinophiles and foreign body 
(silicone) giant cells situated in the submucosa and fascicles 
of striated muscle. Treatment was initiated with deflazacort 15 
mg per day for 10 days and then gradually reducing the dosage 
until withdrawing it completely one month and ten days later. 
The patient noticed a clear improvement although bilateral 
tumefactions of firm consistency persisted on palpation.
Case 2
Female 72 years old, non-smoker nor consumer of alcohol 
and with no clinical history of interest attended our service 
presenting, since eight days previously, a firm, diffuse, facial 
tumefaction, poorly defined although more marked on the lips 
and the chin, with no adenopathies nor alteration in the general 
state of health (fig. 2a). 
The patient informed that 16 years earlier she had undergone 
treatment with injections of dimethylpolysiloxane (silicone) in 
the lips, cheeks and chin. A blood analysis, orthopantomograph, 
FNAB, MRI and biopsy were requested. The first three pro-
vided no data of any help in the diagnosis. The MRI revealed 
an intense inflammatory process affecting almost the entire 
subcutaneous cellular tissue covering the maxillae and the floor 
of the mouth and also a large part of the buccal mucosa (fig.2b). 
The involvement was diffuse and with an extensive contrast. 
The biopsy showed a lesion compatible with a silicone-induced 
foreign body granuloma (fig. 3).
Treatment commenced with deflazacort 30 mg/day, reduced to 
15 and 7.5 at three and two days respectively. One month later 
the patient noticed a worsening of the condition so treatment 
with deflazacort 30 mg/day was reinstated. Three months later, 
the tumefaction persisted and so treatment continued with 7.5 
mg/day of deflazacort. Ten months later, the medication was 
withdrawn. The patient had no problems, but the firmness 
remained in the infiltrated areas.
Case 3
70 year-old woman, occasional smoker and consumer of alco-
hol, with a history of arthrosis, cataracts, detached retina and 
depression. She came to our service presenting a generalized, 
bilateral, facial tumefaction which did not remit with antibiotic 
treatment (fig. 4). Two years previously she had undergone 
treatment with facial collagen infiltrations in the upper lip. The 
patient told how a previous outbreak a year earlier had resulted 
in the extraction of a molar tooth. An orthopantomograph was 
requested and a biopsy taken. The radiography showed no 
signs of any interest. The biopsy revealed discrete perivascular 
lymphoid infiltrates together with a focus of steatonecrosis and 
giant multinucleated cells of a type associated with a foreign 
body reaction. The final diagnosis was infiltration by bovine 
collagen. Treatment commenced with Deflazacort 30 mg/day. 
A gradual improvement of the symptoms occurred over the 
next two weeks. The medication was withdrawn and two wee-
ks later a new outbreak occurred in the right mandibular area 
that required renewed corticoid treatment until its resolution 
10 days later. 
Case 4
A 54-year-old woman with a history of osteoporosis, polyps 
and breast cancer. Under treatment with ossein-hydroxyapatite 
(Osteopor®), extract of melilotus officinalis (Esberiven®) and 
a homeopathic preparation for allergy (Lymphomyosot®). She 
was referred by her dentist, because of the appearance, 15 days 
earlier, of a swelling of the lips and cheeks that had varied in 
intensity and location, sometimes being noticed more on one 
side than on the other. The patient was worried that it might be 
an oral metastasis of breast cancer. Twelve years previously she 
had received silicon infiltrations in the upper nasolabial folds. 
A tumefaction of firm consistency was present in both jugal 
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mucosa up to the retrocommissural area. A blood analysis was 
requested the results of which were normal, and a biopsy was 
taken which confirmed a silicone-induced foreign body reac-
tion. Given the improvement in the patient it was decided not 
to initiate any treatment and to carry out periodic revisions.
Case 5
A forty-three year-old woman with no previous illness of inter-
est who had received silicon injections in the lips and cheeks 
10 years before. At 2-3 years of the infiltrations her face began 
to swell for which she received anti-inflammatory treatment. 
Given that the treatment was ineffective she underwent surgery 
to remove the foreign body. As a result of the surgery the patient 
was left with a facial paralysis without resolving the swelling. 
When she came to service the patient related continuous 
episodes of inflammation that required permanent treatment 
with corticoids (deflazacort) which had caused an increase of 
5kg in weight. On physical examination the patient presented 
labial and buccal mucosa tumefaction above all on the right 
side, firm in consistency. A biopsy was taken which revealed 
a silicone-induced foreign body reaction.
Fig 1. Clinical aspect of case 1. Uneven redness in the areas of tumefaction.
Fig 2a. Intraoral clinical image of case 2.
Fig. 2b. MR of case 2. High contrast, diffuse image of 
facial subcutaneous cellular tissue.
Fig 4. Clinical aspect of case 3. Generalized facial tumefaction.
.
Fig 3. Histology case 2. Vacuoles caused by the filler material.
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DISCUSSION
The clinical and epidemiological characteristics of the cases 
presented in this study are summarised in Table 1.
Independently of the filler material used in each case, the me-
chanism and the end result are the same. The injected product 
induces a reaction in the surrounding conjunctive tissue with 
the more or less stable deposition of collagen that persists in-
dependently of whether the filler material is phagocytized or 
not (2). In short, an increase in the volume of the soft tissues 
is produced, which is the desired effect.
The supposed innocuousness of these products (they were con-
sidered inert initially) was put rapidly into doubt on observing 
adverse reactions directly related with their use. Given that 
silicone was the first material used on a large scale, and with 
little sanitary control, it is responsible for the majority, and the 
most virulent, of the adverse reactions described (4). It should 
be noted, however, that adverse reactions have been described 
to practically all the products used, and, of course, with the 
three materials implicated in this study (5).
Although the possible systemic toxicity of some of these pro-
ducts, in particular silicone, has been suggested, deposits being 
detected in the liver, spleen and kidneys following subcutaneous 
injection, the fact is that it has not been possible to establish a 
relationship with diseases of the conjunctive tissue, nor with 
other diseases (6, 7). Neither has it been possible to detect 
anti-silicone antibodies (8).
Local toxic effects include pain, edema, ecchymosis, erythema, 
dyschromia, alterations in cutaneous texture, overcorrection, 
and local embolic phenomena (3). In some, fortunately rare, ca-
ses extensive ulcers can be produced that can affect muscle, 
bone and nervous structures (9, 10).
The granulomatous foreign body reaction appears after a varia-
ble period (2, 9, 10, 12 and 16 years in the cases presented) and 
from 5 months to 15 years in the literature reviewed (11).
The mechanism remains unknown, although it has been 
suggested that an infection could set off an immunological 
cross-reaction (12) or that retarded immunity stimulation may 
occur (13).
The clinical symptoms include tumefaction – normally solid, 
although other manifestations such as flare, burning sensation, 
pain and sensitivity to touch, which do not appear in the cases 
presented here, have been described (11).
The histology is characterized by giant multi-nucleated cells 
as a foreign body reaction. Vacuoles corresponding to the filler 
material are frequently found, particularly with silicone. With 
other products the filler material may not be detected (2).
The differential diagnosis should include erysipelas, allergic 
contact dermatitis, facial edema with eosinophilia, cheilitis 
glandularis apostematosa, Ascher’s syndrome, orofacial granu-
lomatosis, Crohn’s disease, Melkersson-Rosenthal syndrome 
or sarcoidosis (11.14). Likewise, cutaneous leishmaniasis, 
leprosy or tuberculosis can also present as a granulomatous 
inflammation of the skin (13).
The etiological treatment (removal of the injected substance) 
presents problems that are still difficult to resolve at present. 
For the symptomatic treatment, systemic, local corticoids (12), 
minocycline (15) and imiquimod at 5% (16) have been descri-
bed. Our cases were treated with systemic corticoids during the 
outbreaks since it was considered that the filler material could 
not be removed surgically.
Table 1.  Clinical data of patients with foreign body reaction.
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